Fulgent Genetics
FLGT
14 hedge funds and large institutions have $8.85M invested in Fulgent Genetics in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
17% more capital invested
Capital invested by funds: $7.55M → $8.85M (+$1.3M)
0.3% more ownership
Funds ownership: 6.81% → 7.11% (+0.3%)
13% less funds holding
Funds holding: 16 → 14 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$393K |
| 2 |
RA
Royce & Associates
New York
|
+$89K |
| 3 |
Renaissance Technologies
New York
|
+$36.3K |
| 4 |
BlackRock
New York
|
+$13.9K |
| 5 |
Morgan Stanley
New York
|
+$6.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
-$86K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$62.7K |
| 3 |
MA
Mutual Advisors
Omaha,
Nebraska
|
-$30.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |
FLGT Hedge Fund Activity: Q2 2019 in Review
14 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2019, worth a combined $8.85M — up 17% from $7.55M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of FLGT and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 7 added.
The largest buyer was Essex Investment Management, adding an estimated $393K. The largest seller was Brown Advisory, exiting entirely with an estimated $86K sold.
- 14 institutional investors held Fulgent Genetics (FLGT) as of Q2 2019, down from 16 in Q1 2019.
- Funds reported $8.85M of Fulgent Genetics stock for Q2 2019, up 17% quarter-over-quarter.
- 0 funds opened new Fulgent Genetics positions in Q2 2019 and 2 closed out, a net change of -2 holders.
- The largest Fulgent Genetics buyer in Q2 2019 was Essex Investment Management, an estimated $393K added.
- The largest Fulgent Genetics seller in Q2 2019 was Brown Advisory, an estimated $86K sold.
Based on aggregated 13F filings for Q2 2019.